PF-06826647
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-06826647, covering 2020-03-31 to 2023-06-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa [Phase 2]